We are live on
!
Find out more
LD
Lipe & Dalton Portfolio holdings
AUM
$215M
1-Year Est. Return
39.53%
This Fund
S&P 500
This Quarter
Est. Return
+5.39%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$175M
AUM Growth
+$752K
(+0.43%)
Cap. Flow
-$4.94M
Cap. Flow
% of AUM
-2.83%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
105
New
5
Increased
4
Reduced
58
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ball Corp
BALL
|
+$2.78M |
| 2 |
GE HealthCare
GEHC
|
+$843K |
| 3 |
Zoetis
ZTS
|
+$711K |
| 4 |
Brookfield Asset Management
BAM
|
+$581K |
| 5 |
Palo Alto Networks
PANW
|
+$157K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRE Group
CBRE
|
+$2.24M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.22M |
| 3 |
Baxter International
BAX
|
+$494K |
| 4 |
Douglas Elliman
DOUG
|
+$467K |
| 5 |
BCE
BCE
|
+$350K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Healthcare | 18.81% |
| 3 | Industrials | 17.94% |
| 4 | Financials | 14.63% |
| 5 | Consumer Staples | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
JPMorgan Chase
JPM
$939B
| $210K | 0.12% |
1,615
-65
| -4% | -$8.91K |
|
77
Abbott
ABT
$180B
| $204K | 0.12% |
2,014
| – | – |
|
78
Berkshire Hathaway Class B
BRK.B
$1.07T
| $187K | 0.11% |
605
| – | – |
|
|
79
Palo Alto Networks
PANW
$264B
| $185K | 0.11% |
+1,850
| New | +$157K |
|
80
ExxonMobil
XOM
$651B
| $179K | 0.1% |
1,630
| – | – |
|
81
Mondelez International
MDLZ
$77.7B
| $136K | 0.08% |
1,955
-450
| -19% | -$29.8K |
|
82
Lowe's Companies
LOW
$116B
| $120K | 0.07% |
600
| – | – |
|
83
Winnebago Industries
WGO
$870M
| $115K | 0.07% |
2,000
| – | – |
|
84
Pfizer
PFE
$140B
| $113K | 0.06% |
2,759
| – | – |
|
85
Coca-Cola
KO
$354B
| $112K | 0.06% |
1,800
| – | – |
|
86
Alphabet (Google) Class A
GOOGL
$3.91T
| $108K | 0.06% |
1,040
| – | – |
|
87
Broadcom
AVGO
$1.82T
| $103K | 0.06% |
1,600
| – | – |
|
88
Edwards Lifesciences
EW
$47.6B
| $95K | 0.05% |
1,150
-1,600
| -58% | -$126K |
|
89
PayPal
PYPL
$49.5B
| $91K | 0.05% |
+1,200
| New | +$92.4K |
|
90
ConocoPhillips
COP
$147B
| $86K | 0.05% |
864
| – | – |
|
91
General Mills
GIS
$19.2B
| $69K | 0.04% |
806
| – | – |
|
92
Accenture
ACN
$89.9B
| $66K | 0.04% |
230
| – | – |
|
93
Netflix
NFLX
$292B
| $66K | 0.04% |
1,900
| – | – |
|
94
Duke Energy
DUK
$102B
| $33K | 0.02% |
343
| – | – |
|
95
Chevron
CVX
$388B
| $32K | 0.02% |
197
-340
| -63% | -$57K |
|
96
Walmart Inc
WMT
$871B
| $32K | 0.02% |
660
| – | – |
|
97
Scotiabank
BNS
$106B
| $29K | 0.02% |
575
| – | – |
|
98
Nucor
NUE
$56.4B
| $15K | 0.01% |
100
| – | – |
|
99
Union Pacific
UNP
$183B
| $15K | 0.01% |
75
| – | – |
|
|
ADVM
100
DELISTED
Adverum Biotechnologies
ADVM
| $11K | 0.01% |
1,500
| – | – |
|
Similar funds
VEA
NCM
VFG
SSA
LIWM
IAM
1M
GC
Lipe & Dalton's Q1 2023 Portfolio in Review
As of Q1 2023, Lipe & Dalton held 105 positions worth $175M, up 0.43% from $174M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Lipe & Dalton's Q1 2023 filing shows 5 new, 4 increased, 58 reduced and 3 closed positions. Its largest new stake was Ball Corp: 50,013 shares worth $2.76M. The largest sale was CBRE Group, an estimated $2.24M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
- Lipe & Dalton's largest Q1 2023 buy was Ball Corp: 50,013 shares worth $2.76M.
- Lipe & Dalton added most to Brookfield Asset Management in Q1 2023, an estimated $581K increase.
- Lipe & Dalton's biggest Q1 2023 reduction was Bristol-Myers Squibb, cutting an estimated $1.22M.
- Lipe & Dalton fully exited CBRE Group in Q1 2023, selling an estimated $2.24M.
- Lipe & Dalton's ten largest holdings make up 39% of its $175M portfolio in Q1 2023.
- Lipe & Dalton opened 5 new positions and closed 3 in Q1 2023.
- Lipe & Dalton's portfolio value rose 0.43% quarter-over-quarter to $175M.
Based on Lipe & Dalton's 13F filing for Q1 2023, filed 2 May 2023.